Page last updated: 2024-11-06

reserpine and Breast Neoplasms

reserpine has been researched along with Breast Neoplasms in 74 studies

Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Epidemiological studies of reserpine use and breast cancer have generally found only small increases in breast cancer risk, even after long-term use."7.67Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women. ( Gerkins, VR; Henderson, BE; Krailo, MD; Paganini-Hill, A; Pike, MC; Ross, RK, 1984)
"Although reserpine has an important role in treating patients with hypertension, its appeal was sharply reduced a decade ago when an alleged relationship to breast cancer was reported in case-control studies."7.67Exclusion bias and the false relationship of reserpine and breast cancer. ( Feinstein, AR; Horwitz, RI, 1985)
"To supplement several case-control studies questioning whether use of reserpine is associated with occurrence of breast cancer, we conducted a longitudinal study of nearly 2,000 hypertensive women residing in Rochester, Minn."7.66Reserpine and breast cancer. A community-based longitudinal study of 2,000 hypertensive women. ( Labarthe, DR; O'Fallon, WM, 1980)
"After a series of studies on the linkage of reserpine with breast cancer, both evidence and interpretation appeared to be in conflict."7.66Reserpine and breast cancer. ( Kodlin, D; McCarthy, N, 1978)
"Exposure to reserpine was compared in 181 women interviewed prior to biopsy and found to have breast cancer and 307 women found to have a benign disorder of the breast."7.65Reserpine and breast cancer in women in germany. ( Jesdinsky, HJ; Kewitz, H; Lindtner, E; Schröter, PM, 1977)
" These results do not support the hypothesis that reserpine causes breast cancer."7.65Reserpine and breast cancer in a retirement community. ( Arthur, M; Baptista, J; Gerkins, VR; Henderson, BE; Mack, TM; Pike, MC, 1975)
"Reserpine use was examined for yearly use by each year preceding the diagnosis of breast cancer, by cumulative yearly use, and by other defined time periods."5.25Matched-pairs study of reserpine use and breast cancer. ( Fischer, S; Laska, EM; Meisner, M; Siegel, C; Wanderling, J, 1975)
" Association between the use of reserpine and breast cancer in women, between atenolol and some types of cancer in elderly men also can not be ruled out."4.81[Antihypertensive drugs and malignant neoplasia]. ( Kiktev, VG; Preobrazhenskiĭ, DV; Sidorenko, BA; Stetsenko, TM, 2002)
" Early retrospective studies implicated reserpine in breast cancer, but data from prospective studies and meta-analysis of several case-controlled studies showed only a weak association between reserpine and breast cancer which, although statistically significant, is of little clinical concern."4.81Carcinogenicity of antihypertensive therapy. ( Goldbourt, U; Grossman, E; Messerli, FH, 2002)
" Early retrospective studies implicated reserpine in breast cancer, but the drug was later absolved by prospective analyses."4.80Carcinogenicity of cardiovascular drugs. ( Goldbourt, U; Grossman, E; Messerli, FH, 1999)
"; demographic characteristics of breast cancer cases; international variation; laterality of breast cancer; reproductive variables; benign breast diseases; multiple primary cancers involving the breast and other sites; familial aggregation and genetics; endogenous hormones (estrogens, progesterone, prolactin, androgens, and thyroid); exogenous estrogens; diet; body build; radiation; exposure to radiation in screening for breast cancer; mammographic parenchymal patterns; viruses; other exposures of current interest (reserpine, hair dyes); and breast cancer in males."4.76A review of the epidemiology of human breast cancer. ( Kelsey, JL, 1979)
"Epidemiological studies of reserpine use and breast cancer have generally found only small increases in breast cancer risk, even after long-term use."3.67Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women. ( Gerkins, VR; Henderson, BE; Krailo, MD; Paganini-Hill, A; Pike, MC; Ross, RK, 1984)
"Although reserpine has an important role in treating patients with hypertension, its appeal was sharply reduced a decade ago when an alleged relationship to breast cancer was reported in case-control studies."3.67Exclusion bias and the false relationship of reserpine and breast cancer. ( Feinstein, AR; Horwitz, RI, 1985)
" Intermittently elevated prolactin levels have been noted in some women who subsequently developed breast cancer, but epidemiologic studies of women who have received prolactin-releasing drugs such as reserpine and perphenazine have not disclosed increased risk."3.66Hormones, medications, and cancer. ( Lipsett, MB, 1983)
"To supplement several case-control studies questioning whether use of reserpine is associated with occurrence of breast cancer, we conducted a longitudinal study of nearly 2,000 hypertensive women residing in Rochester, Minn."3.66Reserpine and breast cancer. A community-based longitudinal study of 2,000 hypertensive women. ( Labarthe, DR; O'Fallon, WM, 1980)
"After a series of studies on the linkage of reserpine with breast cancer, both evidence and interpretation appeared to be in conflict."3.66Reserpine and breast cancer. ( Kodlin, D; McCarthy, N, 1978)
"Exposure to reserpine was compared in 181 women interviewed prior to biopsy and found to have breast cancer and 307 women found to have a benign disorder of the breast."3.65Reserpine and breast cancer in women in germany. ( Jesdinsky, HJ; Kewitz, H; Lindtner, E; Schröter, PM, 1977)
"During the course of a collaborative study initiated in investigate the relationship of breast cancer and the use of hormones, it was possible to study the possible relationship of rauwolfia derivatives, mainly reserpine, to breast cancer."3.65Rauwolfia derivatives and breast cancer. ( Chang, L; Levin, ML; Lilienfeld, AM; Thomas, DB, 1976)
" These results do not support the hypothesis that reserpine causes breast cancer."3.65Reserpine and breast cancer in a retirement community. ( Arthur, M; Baptista, J; Gerkins, VR; Henderson, BE; Mack, TM; Pike, MC, 1975)
"Among the 48 human ABC proteins, the breast cancer resistance protein (BCRP/ABCG2) has been described as a pivotal player in cancer resistance."2.82Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators. ( Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF, 2022)
"The association between diuretics and renal cell carcinoma was analysed in 4389 cases and 6566 controls, yielding a pooled OR of 1."2.41Antihypertensive therapy and the risk of malignancies. ( Goldbourt, U; Grossman, E; Messerli, FH, 2001)
"A case control study in breast cancer was conducted in France between 1976 and 1980."1.26[Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)]. ( Clavel, F; Laplanche, A; Lê, M, 1981)
"Reserpine use was examined for yearly use by each year preceding the diagnosis of breast cancer, by cumulative yearly use, and by other defined time periods."1.25Matched-pairs study of reserpine use and breast cancer. ( Fischer, S; Laska, EM; Meisner, M; Siegel, C; Wanderling, J, 1975)
"Using breast carcinoma in women as an example, it is shown that a carcinogenic effect cannot be demonstrated for two of the supposed carcinogenic factors, namely repeated diagnostic radiographic measures and administration of Rauwolfia-alkaloid containing drugs."1.25[Breast cancer in women as a paradigm for ageing as a hidden syncarcinogenic factor]. ( Fuchs, G; Oeser, H, 1975)

Research

Studies (74)

TimeframeStudies, this research(%)All Research%
pre-199065 (87.84)18.7374
1990's3 (4.05)18.2507
2000's5 (6.76)29.6817
2010's0 (0.00)24.3611
2020's1 (1.35)2.80

Authors

AuthorsStudies
Pick, A1
Müller, H1
Wiese, M1
Zattoni, IF1
Delabio, LC1
Dutra, JP1
Kita, DH1
Scheiffer, G1
Hembecker, M1
Pereira, GDS1
Moure, VR1
Valdameri, G1
Sieber, M1
Preobrazhenskiĭ, DV1
Sidorenko, BA1
Stetsenko, TM1
Kiktev, VG1
VANORDEN, LS1
VUGMAN, I1
GIARMAN, NJ1
LACASSAGNE, A1
DUPLAN, JF1
Głuszek, S1
Caffier, H1
Ross, RK1
Paganini-Hill, A1
Krailo, MD1
Gerkins, VR2
Henderson, BE2
Pike, MC2
Lipsett, MB1
Clavel, F1
Lê, M1
Laplanche, A1
Feferman, I1
Labarthe, DR2
O'Fallon, WM2
Kewitz, H3
Jesdinsky, HJ3
Kreutz, G1
Schulz, R1
Fraser, HS1
Grossman, E3
Messerli, FH3
Goldbourt, U3
Schyve, PM1
Smithline, F1
Meltzer, HY1
Bishun, N1
Smith, N1
Williams, D1
Laska, EM1
Siegel, C1
Meisner, M1
Fischer, S1
Wanderling, J1
Larbarthe, DR1
Williams, RR2
Schröter, PM2
Lindtner, E2
Christopher, LJ1
Crooks, J1
Moir, D1
Weir, RD1
Bolt, HM1
Byar, DP1
Blackard, CE1
Feinleib, M1
Connor, RJ1
Stegens, NL1
Margreiter, R1
Kelsey, JL1
Gunby, P1
Tikhonova, NA1
Lazarev, NI1
Samoĭlenko, LA1
Kodlin, D1
McCarthy, N1
Schmähl, D1
Levin, ML2
Thomas, DB2
Lilienfeld, AM1
Chang, L1
Jick, H2
Oeser, H1
Fuchs, G1
Modan, B2
Wedel, H1
Wilhelmsen, L1
Freis, ED1
Mack, TM1
Arthur, M1
Baptista, J1
Waard, FD1
Utrecht, T1
Klinkhamer, AC1
Simon, KH1
Greenland, S1
Widmer, RB1
de Waard, F1
Horwitz, RI1
Feinstein, AR1
Skutsch, GM1
Cazenave, JP1
Reimers, HJ1
Perey, DY1
Mustard, JF1
Armstrong, B1
Stevens, N1
Doll, R1
Heinonen, OP1
Shapiro, S1
Tuominen, L1
Turunen, MI1
Immich, H1
Soost, HJ1
Ries, P1
Böttiger, LE1
Teppo, L1
Hakama, M1
Givens, JR1
Camacho, A1
Patterson, P1

Reviews

11 reviews available for reserpine and Breast Neoplasms

ArticleYear
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
    European journal of medicinal chemistry, 2022, Jul-05, Volume: 237

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Dr

2022
[Antihypertensive drugs and malignant neoplasia].
    Kardiologiia, 2002, Volume: 42, Issue:5

    Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; Age Factors; Aged; Angiotensin-Converting

2002
[Reserpine and breast cancer].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1984, Mar-01, Volume: 37, Issue:5

    Topics: Breast; Breast Neoplasms; Cocarcinogenesis; Estrogens; Female; Humans; Hypertension; Prolactin; Prol

1984
[Genesis of breast cancer: a multifactorial etiology].
    Medizinische Klinik, 1980, Sep-26, Volume: 75, Issue:20

    Topics: Animals; Breast Neoplasms; Estrogens; Female; Fibrocystic Breast Disease; Hormones; Humans; Mammary

1980
Reserpine: a tragic victim of myths, marketing, and fashionable prescribing.
    Clinical pharmacology and therapeutics, 1996, Volume: 60, Issue:4

    Topics: Adrenergic Antagonists; Antihypertensive Agents; Breast Neoplasms; Dose-Response Relationship, Drug;

1996
Carcinogenicity of cardiovascular drugs.
    Current hypertension reports, 1999, Volume: 1, Issue:3

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Brea

1999
Antihypertensive therapy and the risk of malignancies.
    European heart journal, 2001, Volume: 22, Issue:15

    Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aten

2001
Carcinogenicity of antihypertensive therapy.
    Current hypertension reports, 2002, Volume: 4, Issue:3

    Topics: Animals; Antihypertensive Agents; Breast Neoplasms; Carcinogens; Humans; Hypertension; Longitudinal

2002
Reserpine.
    IARC monographs on the evaluation of the carcinogenic risk of chemicals to man, 1976, Volume: 10

    Topics: Animals; Breast Neoplasms; Carcinogens; Carcinoma, Hepatocellular; Drug Evaluation, Preclinical; Fem

1976
[Epidemiology of breast cancer].
    Wiener medizinische Wochenschrift (1946), 1978, Dec-30, Volume: 128, Issue:24

    Topics: Adult; Age Factors; Breast Neoplasms; Estrogens; Female; Geography; Gonadal Steroid Hormones; Humans

1978
A review of the epidemiology of human breast cancer.
    Epidemiologic reviews, 1979, Volume: 1

    Topics: Adult; Androgens; Breast Diseases; Breast Neoplasms; Contraceptives, Oral; Diet; Estrogens; Europe;

1979

Trials

1 trial available for reserpine and Breast Neoplasms

ArticleYear
Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Metabolism: clinical and experimental, 1970, Volume: 19, Issue:10

    Topics: 17-Hydroxycorticosteroids; Addison Disease; Adrenal Glands; Adult; Aldosterone; Aminoglutethimide; A

1970

Other Studies

62 other studies available for reserpine and Breast Neoplasms

ArticleYear
Structure-activity relationships of new inhibitors of breast cancer resistance protein (ABCG2).
    Bioorganic & medicinal chemistry, 2008, Sep-01, Volume: 16, Issue:17

    Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member

2008
[Identification of risk factors (the method of logistic regression)].
    Praxis, 2008, Jul-09, Volume: 97, Issue:14

    Topics: Aged; Breast Neoplasms; Confidence Intervals; Female; Humans; Logistic Models; Male; Middle Aged; My

2008
5-HYDROXYTRYPTAMINE IN SINGLE NEOPLASTIC MAST CELLS: A MICROSCOPIC SPECTROFLUOROMETRIC STUDY.
    Science (New York, N.Y.), 1965, Apr-30, Volume: 148, Issue:3670

    Topics: Animals; Breast Neoplasms; Catecholamines; Fluorescence; Fluorometry; Histamine; Humans; Mammary Neo

1965
[The mechanism of canceration of the breast in mice, considered after the results of experiments with reserpine].
    Comptes rendus hebdomadaires des seances de l'Academie des sciences, 1959, Aug-10, Volume: 249

    Topics: Animals; Breast; Breast Neoplasms; Mammary Neoplasms, Experimental; Mice; Reserpine

1959
Effects of reserpine on prolactin levels and incidence of breast cancer in postmenopausal women.
    Cancer research, 1984, Volume: 44, Issue:7

    Topics: Aged; Antihypertensive Agents; Breast Neoplasms; California; Female; Humans; Menopause; Prolactin; R

1984
Hormones, medications, and cancer.
    Cancer, 1983, Jun-15, Volume: 51, Issue:12 Suppl

    Topics: Animals; Breast Neoplasms; Cocarcinogenesis; Drug-Related Side Effects and Adverse Reactions; Epidem

1983
[Breast cancer and use of antihypertensive drugs and oral contraceptives: results of a case-control study (author's transl)].
    Bulletin du cancer, 1981, Volume: 68, Issue:5

    Topics: Adult; Antihypertensive Agents; Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combin

1981
The hypertensive patient.
    Canadian Medical Association journal, 1980, Feb-09, Volume: 122, Issue:3

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Reserpine

1980
Reserpine and breast cancer. A community-based longitudinal study of 2,000 hypertensive women.
    JAMA, 1980, Jun-13, Volume: 243, Issue:22

    Topics: Benzothiadiazines; Breast Neoplasms; Diuretics; Drug Interactions; Female; Humans; Hypertension; Lon

1980
Reserpine and breast cancer.
    Archives internationales de pharmacodynamie et de therapie, 1980, Volume: Suppl

    Topics: Breast Neoplasms; Chronic Disease; Female; Humans; Hypertension; Reserpine

1980
Neuroleptic-induced prolactin level elevation and breast cancer: an emerging clinical issue.
    Archives of general psychiatry, 1978, Volume: 35, Issue:11

    Topics: Animals; Antipsychotic Agents; Breast Neoplasms; Female; Hospitals, Psychiatric; Humans; Male; Mamma

1978
Letter: Chromsomes, mitosis, and reserpine.
    Lancet (London, England), 1975, Apr-19, Volume: 1, Issue:7912

    Topics: Breast Neoplasms; Chromosomes; Culture Techniques; Female; Humans; Leukocytes; Mitosis; Reserpine

1975
Matched-pairs study of reserpine use and breast cancer.
    Lancet (London, England), 1975, Aug-16, Volume: 2, Issue:7929

    Topics: Aged; Breast Neoplasms; Diagnosis, Computer-Assisted; Family Characteristics; Female; Hospital Recor

1975
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1975, Oct-18, Volume: 2, Issue:7938

    Topics: Breast Neoplasms; Female; Humans; Reserpine; Time Factors

1975
Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, T.S.H. and M.S.H.
    Lancet (London, England), 1976, May-08, Volume: 1, Issue:7967

    Topics: Alcoholism; Breast Neoplasms; Ethanol; Female; Humans; Male; Melanocyte-Stimulating Hormones; Melano

1976
Reserpine and breast cancer.
    Lancet (London, England), 1976, Dec-11, Volume: 2, Issue:7998

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Middle Aged; Reserpine

1976
Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1977, Jan-15, Volume: 1, Issue:8003

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Reserpine; Retrospective Studies; Scotland

1977
[The importance of estrogen receptors in the pharmacotherapy of mammary carcinoma (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1975, Feb-28, Volume: 117, Issue:9

    Topics: Androgens; Breast Neoplasms; Castration; Cytoplasm; Estrogen Antagonists; Estrogens; Female; Humans;

1975
Letters: Rserpine and prostatic cancer.
    Urology, 1975, Volume: 5, Issue:1

    Topics: Animals; Breast Neoplasms; Carcinoma 256, Walker; Cell Transformation, Neoplastic; Dextrans; Drug Ev

1975
Case-control study of antihypertensive and diuretic use by women with malignant and benign breast lesions detected in a mammography screening program.
    Journal of the National Cancer Institute, 1978, Volume: 61, Issue:2

    Topics: Adult; Aged; Antihypertensive Agents; Benzothiadiazines; Breast Neoplasms; Diuretics; Epidemiologic

1978
More on the subject of reserpine.
    JAMA, 1979, Jun-15, Volume: 241, Issue:24

    Topics: Adrenal Gland Neoplasms; Animals; Breast Neoplasms; Female; Humans; Hypertension; Male; Mice; Rats;

1979
Methodologic variation in case-control studies of reserpine and breast cancer.
    Journal of chronic diseases, 1979, Volume: 32, Issue:1-2

    Topics: Breast Neoplasms; Epidemiologic Methods; Female; Humans; Registries; Research Design; Reserpine; Ret

1979
[Is there a basis for the suggested significance of rauwolfia preparations in the development of breast cancer?].
    Klinicheskaia meditsina, 1979, Volume: 57, Issue:5

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Reserpine

1979
Reserpine and breast cancer.
    Cancer, 1978, Volume: 41, Issue:2

    Topics: Age Factors; Aged; Breast Neoplasms; Epidemiologic Methods; Female; Humans; Hypertension; Reserpine;

1978
[Carcinogenic effect of reserpine?].
    Deutsche medizinische Wochenschrift (1946), 1978, Nov-17, Volume: 103, Issue:46

    Topics: Breast Neoplasms; Female; Humans; Neoplasms; Reserpine

1978
Reserpine and breast cancer in women in germany.
    European journal of clinical pharmacology, 1977, Jan-03, Volume: 11, Issue:2

    Topics: Adult; Age Factors; Aged; Breast Neoplasms; Female; Germany, West; Humans; Hypertension; Middle Aged

1977
The epidemiology of breast cancer.
    Progress in clinical and biological research, 1977, Volume: 12

    Topics: Adult; Age Factors; Aged; Breast Diseases; Breast Neoplasms; Dietary Fats; Estrogens; Ethnicity; Fem

1977
Rauwolfia derivatives and breast cancer.
    The Johns Hopkins medical journal, 1976, Volume: 139, Issue:2

    Topics: Adolescent; Adult; Aged; Breast Neoplasms; Female; Hospitalization; Humans; Hypertension; Maryland;

1976
Berkson fallacy and studies on reserpine and breast cancer.
    American journal of diseases of children (1960), 1976, Volume: 130, Issue:10

    Topics: Breast Neoplasms; Epidemiologic Methods; Female; Humans; Reserpine; Statistics as Topic

1976
Editorial: Reserpine and breast cancer.
    Canadian Medical Association journal, 1975, Jan-25, Volume: 112, Issue:2

    Topics: Age Factors; Aged; Brain Neoplasms; Breast Neoplasms; Female; Humans; Kidney Neoplasms; Middle Aged;

1975
[Breast cancer in women as a paradigm for ageing as a hidden syncarcinogenic factor].
    Deutsche medizinische Wochenschrift (1946), 1975, Mar-07, Volume: 100, Issue:10

    Topics: Age Factors; Aging; Breast Neoplasms; Carcinogens; Female; Humans; Radiography; Reserpine; Secologan

1975
[Editorial: Is reserpine medication associated with increased risk of breast cancer?].
    Harefuah, 1975, Jan-15, Volume: 88, Issue:2

    Topics: Breast Neoplasms; Female; Humans; Reserpine

1975
[Reserpine and breast neoplasms].
    Lakartidningen, 1975, Jan-22, Volume: 72, Issue:4

    Topics: Age Factors; Breast Neoplasms; Female; Humans; Reserpine

1975
Reserpine in hypertension: present status.
    American family physician, 1975, Volume: 11, Issue:6

    Topics: Animals; Benzothiadiazines; Breast Neoplasms; Chronic Disease; Depression; Diuretics; Drug Therapy,

1975
Reserpine and breast cancer in a retirement community.
    The New England journal of medicine, 1975, Jun-26, Volume: 292, Issue:26

    Topics: Aged; Breast Neoplasms; California; Community Health Services; Epidemiologic Methods; Female; Humans

1975
[Rauwolfia alkaloids and cancer].
    Nederlands tijdschrift voor geneeskunde, 1975, May-03, Volume: 119, Issue:18

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Reserpine

1975
[Announcement of reserpine gave a fast effect].
    Nordisk medicin, 1975, Volume: 90, Issue:6-7

    Topics: Breast Neoplasms; Female; Humans; Reserpine

1975
[Mammography-why, when, how].
    Nederlands tijdschrift voor geneeskunde, 1975, Aug-02, Volume: 119, Issue:31

    Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Mammography; Mass Screening; Mastect

1975
Editorial: Reserpine and breast cancer: a perspective.
    JAMA, 1975, Aug-25, Volume: 233, Issue:8

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Reserpine; United States; United States Food and Dru

1975
[Does reserpine cause breast cancer?--So far no].
    Medizinische Monatsschrift, 1975, Volume: 29, Issue:7

    Topics: Breast Neoplasms; Female; Humans; Reserpine

1975
[Editorial: Reserpine and breast cancer--end of the affair?].
    Harefuah, 1976, Apr-01, Volume: 90, Issue:7

    Topics: Breast Neoplasms; Female; Humans; Reserpine

1976
Science versus advocacy: the challenge of Dr. Feinstein.
    Epidemiology (Cambridge, Mass.), 1991, Volume: 2, Issue:1

    Topics: Alcoholism; Breast Neoplasms; Epidemiologic Methods; Estrogens; Female; Humans; Infant, Newborn; Jur

1991
Reserpine: the maligned antihypertensive drug.
    The Journal of family practice, 1985, Volume: 20, Issue:1

    Topics: Antihypertensive Agents; Breast Neoplasms; Depression; Depressive Disorder; Humans; Hypertension; Re

1985
Endocrinological studies on breast cancer in the framework of a screening programme.
    Maturitas, 1985, Volume: 7, Issue:1

    Topics: Age Factors; Androgens; Body Constitution; Breast; Breast Neoplasms; Creatinine; Estrogens; Female;

1985
Exclusion bias and the false relationship of reserpine and breast cancer.
    Archives of internal medicine, 1985, Volume: 145, Issue:10

    Topics: Aged; Breast Neoplasms; Cardiovascular Diseases; Epidemiologic Methods; Female; Humans; Menopause; M

1985
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1974, Oct-05, Volume: 2, Issue:7884

    Topics: Breast Neoplasms; Female; Humans; Reserpine; Retrospective Studies

1974
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1974, Oct-19, Volume: 2, Issue:7886

    Topics: Boston; Breast Neoplasms; Drug Evaluation; England; Evaluation Studies as Topic; Female; Finland; He

1974
Letter: Reserpine, prolactin, allergy, and breast cancer.
    Lancet (London, England), 1974, Oct-19, Volume: 2, Issue:7886

    Topics: Breast Neoplasms; Female; Humans; Hyperemesis Gravidarum; Hypersensitivity; Immunity; Pregnancy; Pro

1974
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1974, Nov-23, Volume: 2, Issue:7891

    Topics: Antihypertensive Agents; Breast Neoplasms; Female; Humans; Lymphocyte Activation; Reserpine

1974
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1974, Nov-30, Volume: 2, Issue:7892

    Topics: Antihypertensive Agents; Breast Neoplasms; Female; Finland; Humans; Hypertension; Male; Middle Aged;

1974
Letter: Rauwolfia derivatives and breast cancer.
    Lancet (London, England), 1974, Dec-28, Volume: 2, Issue:7896

    Topics: Breast Neoplasms; Cell Transformation, Neoplastic; Female; Humans; Neoplasm Metastasis; Reserpine

1974
Reserpine and breast cancer.
    Lancet (London, England), 1974, Sep-21, Volume: 2, Issue:7882

    Topics: Adult; Age Factors; Aged; Boston; Breast Neoplasms; Female; Humans; Hypertension; Middle Aged; Reser

1974
Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women.
    Lancet (London, England), 1974, Sep-21, Volume: 2, Issue:7882

    Topics: Aged; Antihypertensive Agents; Breast Neoplasms; England; Female; Humans; Hypertension; Middle Aged;

1974
Reserpine use in relation to breast cancer.
    Lancet (London, England), 1974, Sep-21, Volume: 2, Issue:7882

    Topics: Age Factors; Aged; Breast Neoplasms; Female; Finland; Humans; Hypertension; Middle Aged; Reserpine;

1974
Editorial: Rauwolfia derivatives and cancer.
    Lancet (London, England), 1974, Sep-21, Volume: 2, Issue:7882

    Topics: Breast Neoplasms; Drug Evaluation; Female; Humans; Hypertension; Middle Aged; Reserpine; Secologanin

1974
Letter: Rauwolfia derivatives and cancer.
    Lancet (London, England), 1974, Sep-28, Volume: 2, Issue:7883

    Topics: Adult; Age Factors; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Reserpine; Retrospective St

1974
[Secretion and hemorrhage from the breast. Causes and cytodiagnosis].
    Munchener medizinische Wochenschrift (1950), 1969, Apr-25, Volume: 111, Issue:17

    Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Aged; Amenorrhea; Breast; Breast Diseases; Breast N

1969
Editorial: Rauwolfia and breast cancer.
    British medical journal, 1974, Oct-19, Volume: 4, Issue:5937

    Topics: Breast Neoplasms; Depression; Female; Humans; Hypertension; Menopause; Methyldopa; Middle Aged; Phyt

1974
[Rauwolfia preparations and breast cancer].
    Ugeskrift for laeger, 1974, Nov-04, Volume: 136, Issue:45

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Phytotherapy; Plants, Medicinal; Rauwolfia; Reserpin

1974
[Reserpine and breast cancer].
    Lakartidningen, 1974, Nov-13, Volume: 71, Issue:46

    Topics: Breast Neoplasms; Female; Humans; Hypertension; Middle Aged; Reserpine

1974
Editorial: Rauwolfia derivatives and breast cancer.
    The Medical journal of Australia, 1974, Nov-16, Volume: 2, Issue:20

    Topics: Breast Neoplasms; Female; Humans; Middle Aged; Plants, Medicinal; Prolactin; Rauwolfia; Reserpine; S

1974
[Reserpine and breast cancer].
    Duodecim; laaketieteellinen aikakauskirja, 1974, Volume: 90, Issue:23

    Topics: Antihypertensive Agents; Boston; Breast Neoplasms; Female; Finland; Humans; Reserpine; Surveys and Q

1974